Aspire Biopharma Holdings Overview
Aspire Biopharma Holdings (ASBP) has a P/E ratio of -1.06, below the sector sector average of 35.6.
Get informed when a big investor buys or sells
+ Follow-1.06
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, ASBP shows a P/E ratio of -1.06. That is below the sector sector average of 35.6. Scroll down for historical charts and peer comparison views.
The its sector sector average P/E ratio is about 35.6. Aspire Biopharma Holdings is at -1.06, which is lower that average. That is roughly 103.0% below the sector mean. Use the comparison chart on this page to see how ASBP stacks up against individual peers as well.
Investors watch ASBP's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Aspire Biopharma Holdings's latest reading is -1.06. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Aspire Biopharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -1.06) with ownership activity and broader fundamentals.
